Literature DB >> 10377109

Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.

C R Brown1, S L Reiner.   

Abstract

Genetic resistance and susceptibility to experimental Lyme arthritis have been linked with the production of interleukin-4 (IL-4) or gamma interferon (IFN-gamma), respectively. To determine the absolute requirement for these cytokines in disease outcome, we compared arthritis development in wild-type, IL-4-deficient (IL-4 degrees ), and IFN-gamma-deficient (IFN-gamma degrees ) mice. While susceptible C3H mice developed swelling of ankle joints during the second week of infection, this swelling was exacerbated in C3H IFN-gamma degrees mice. Their arthritis severity scores at day 21, however, were similar. Resolution of arthritis was also similar between C3H and C3H IFN-gamma degrees mice. Arthritis-resistant DBA mice did not develop ankle swelling during the experimental period. There were no differences in ankle swelling or arthritis severity scores between control DBA mice and DBA IL-4 degrees mice at any of the time points tested. While the presence of spirochetes in various tissues was similar among all strains at day 21, DBA IL-4 degrees mice had a higher presence of spirochetes in blood, heart, and spleen than the DBA, C3H, and C3H IFN-gamma degrees mice did at day 60. DBA IL-4 degrees mice also had impaired ability to produce Borrelia-specific antibody responses, especially immunoglobulin G1. Thus, while IFN-gamma and IL-4 are not absolutely required for arthritis susceptibility or resistance, the production of IL-4 does appear to play an important role in Borrelia-specific antibody production and spirochete clearance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377109      PMCID: PMC116514     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models.

Authors:  F D Finkelman; T Shea-Donohue; J Goldhill; C A Sullivan; S C Morris; K B Madden; W C Gause; J F Urban
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

2.  Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; S Feng; L K Bockenstedt; E Fikrig; K Feen
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

3.  B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.

Authors:  J Anguita; R Roth; S Samanta; R J Gee; S W Barthold; M Mamula; E Fikrig
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.

Authors:  A Keane-Myers; C R Maliszewski; F D Finkelman; S P Nickell
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

5.  Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis.

Authors:  J Oksi; J Savolainen; J Pène; J Bòusquet; P Laippala; M K Viljanen
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  Susceptibility to Leishmania major infection in interleukin-4-deficient mice.

Authors:  N Noben-Trauth; P Kropf; I Müller
Journal:  Science       Date:  1996-02-16       Impact factor: 47.728

7.  Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).

Authors:  I A Ferber; S Brocke; C Taylor-Edwards; W Ridgway; C Dinisco; L Steinman; D Dalton; C G Fathman
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

8.  Serum-mediated resolution of Lyme arthritis in mice.

Authors:  S W Barthold; M deSouza; S Feng
Journal:  Lab Invest       Date:  1996-01       Impact factor: 5.662

9.  Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells.

Authors:  A B Frey; T D Rao
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Protective resistance to experimental Borrelia burgdorferi infection of mice by adoptive transfer of a CD4+ T cell clone.

Authors:  T D Rao; A B Frey
Journal:  Cell Immunol       Date:  1995-05       Impact factor: 4.868

View more
  41 in total

1.  Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism.

Authors:  Marije Oosting; Frank L van de Veerdonk; Thirumala-Devi Kanneganti; Patrick Sturm; Ineke Verschueren; Anneleen Berende; Jos W M van der Meer; Bart-Jan Kullberg; Mihai G Netea; Leo A B Joosten
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

2.  Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.

Authors:  C Ekerfelt; M Andersson; A Olausson; S Bergström; P Hultman
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

3.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease.

Authors:  Xiaohui Wang; Ying Ma; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 5.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

6.  Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.

Authors:  M R Potter; N Noben-Trauth; J H Weis; C Teuscher; J J Weis
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

7.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

Review 8.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

9.  A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice.

Authors:  Jennifer C Miller; Ying Ma; Jiantao Bian; Kathleen C F Sheehan; James F Zachary; John H Weis; Robert D Schreiber; Janis J Weis
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains.

Authors:  Sharon Lederer; Christiane Brenner; Thomas Stehle; Lise Gern; Reinhard Wallich; Markus M Simon
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.